Efficacy and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Measure Up 1, Measure Up 2, and AD Up Phase 3 Clinical Trials at 52 Weeks

被引：0

作者：

Paller, Amy ^{[1
]}

Mendes-Bastos, Pedro ^{[2
]}

Eichenfield, Lawrence ^{[3
,4
,5
]}

Soong, Weily ^{[6
]}

Lio, Peter ^{[7
]}

Prajapati, Vimal ^{[8
,9
,10
]}

Platt, Andrew ^{[11
]}

Liu, John ^{[11
]}

Ladizinski, Barry ^{[11
]}

Thyssen, Jacob

机构：

[1] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL USA

[2] Hosp CUF Descobertas, Dermatol Ctr, Lisbon, Portugal

[3] Univ Calif San Diego, Sch Med, Rady Childrens Hosp, Div Pediat & Adolescent Dermatol, San Diego, CA USA

[4] Univ Calif San Diego, Sch Med, Dept Dermatol, San Diego, CA USA

[5] Univ Calif San Diego, Sch Med, Dept Pediat, San Diego, CA USA

[6] AllerVie HealthAlabama Allergy & Asthma Ctr & Cli, Birmingham, AL USA

[7] Med Dermatol Associates Chicago, Chicago, IL USA

[8] Univ Calgary, Div Dermatol, Dept Med, Calgary, AB, Canada

[9] Univ Calgary, Sect Community Pediat, Dept Pediat, Calgary, AB, Canada

[10] Univ Calgary, Sect Pediat Rheumatol, Calgary, AB, Canada

[11] AbbVie Inc, N Chicago, IL USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

43049

引用

页码：AB157 / AB157

页数：1

共 50 条

[41] Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies
Guttman-Yassky, Emma
Thyssen, Jacob P.
Silverberg, Jonathan I.
Papp, Kim A.
Paller, Amy S.
Weidinger, Stephan
Hong, H. Chih-ho
Hendrickson, Barbara
Dilley, Deanne
Tenorio, Allan R.
Ladizinski, Barry
Chu, Alvina D.
Liu, John
Irvine, Alan D.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (01) : 172 - 181
[42] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults: A pooled analysis of two phase 2 clinical trials
Tofte, Susan J.
Papp, Kim
Sadick, Neil
Bohnert, Krista
Simpson, Eric
Thaci, Diamant
Bieber, Thomas
Blauvelt, Andrew
Sofen, Howard
Gooderham, Melinda
Chen, Zhen
Gadkari, Abhijit
Eckert, Laurent
Graham, Neil M. H.
Pirozzi, Gianluca
Ardeleanu, Marius
JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2018, 30 (09): : 529 - 541
[43] Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials
Gold, Linda Stein
Thaci, Diamant
Thyssen, Jacob P.
Gooderham, Melinda
Laquer, Vivian
Moore, Angela
Natalie, Chitra R.
Zhao, Fangyi
Meskimen, Eric
Elmaraghy, Hany
Montmayeur, Sonia
Gallo, Gaia
Jimenez, Gemma
de Bruin-Weller, Marjolein
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (04) : 595 - 607
[44] Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial
Blauvelt, Andrew
Teixeira, Henrique D.
Simpson, Eric L.
Costanzo, Antonio
De Bruin-Weller, Marjolein
Barbarot, Sebastien
Prajapati, Vimal H.
Lio, Peter
Hu, Xiaofei
Wu, Tianshuang
Liu, John
Ladizinski, Barry
Chu, Alvina D.
Eyerich, Kilian
JAMA DERMATOLOGY, 2021, 157 (09) : 1047 - 1055
[45] Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials
Linda Stein Gold
Diamant Thaçi
Jacob P. Thyssen
Melinda Gooderham
Vivian Laquer
Angela Moore
Chitra R. Natalie
Fangyi Zhao
Eric Meskimen
Hany Elmaraghy
Sonia Montmayeur
Gaia Gallo
Gemma Jimenez
Marjolein de Bruin-Weller
American Journal of Clinical Dermatology, 2023, 24 : 595 - 607
[46] Discontinuation of topical corticosteroids in upadacitinib-treated patients with moderate-to-severe atopic dermatitis: analysis from the AD Up phase III trial
Reich, K.
Boguniewicz, M.
Kabashima, K.
Barbarot, S.
Girolomoni, G.
Mendes-Bastos, P.
Gamelli, A.
Liu, Y.
Teixeira, H.
Armstrong, A.
BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E118 - E118
[47] Efficacy and Safety of Upadacitinib versus Dupilumab Treatment for Moderate-to-Severe Atopic Dermatitis in Four Body Regions: Analysis from the Heads Up Study
Thyssen, Jacob P.
Rosmarin, David
Costanzo, Antonio
Warren, Richard
Chu, Chia-Yu
Chovatiya, Raj
Ladizinski, Barry
Hu, Xiaofei
Liu, Yingyi
Calimlim, Brian
Nduaka, Chudi
Vigna, Namita
Armstrong, April
DERMATOLOGY, 2025, 241 (01) : 10 - 18
[48] Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis: results from the pivotal phase III, randomized, double-blind, placebo-controlled AD Up study
Reich, K.
Teixeira, H. D.
De Bruin-Weller, M.
Bieber, T.
Soong, W.
Kabashima, K.
Werfel, T.
Zeng, J.
Huang, X.
Hu, X.
Ladizinski, B.
Chu, A. D.
Silverberg, J. I.
BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : E59 - E60
[49] Effects of upadacitinib on the patient-reported impact of atopic dermatitis: Atopic Dermatitis Impact Scale (ADerm-IS) results from two pivotal phase 3 studies (MEASURE UP 1 and MEASURE UP 2)
Simpson, Eric L.
de Bruin-Weller, Marjolein S.
Prajapati, Vimal H.
Calimlim, Brian M.
Teixeira, Henrique D.
Zeng, Jiewei
Liu, Meng
Silverberg, Jonathan I.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB60 - AB60
[50] Efficacy and safety of upadacitinib in the treatment of moderate-to-severe atopic dermatitis in adolescents: A systematic review and meta-analysis of randomized controlled trials
Huang, Lingmei
Zhao, Danjie
Lin, Haixia
Zheng, Hong
Li, Xia
Chen, Long
Tang, Peng
MEDICINE, 2024, 103 (38)

← 1 2 3 4 5 →